The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Perspective: Alpha-Bugs, Their Microbial Partners, and the Link to Colon Cancer
Open accessAbstract
A dramatic intersection between the infectious diseases and oncology fields has emerged from the appreciation that many cancers arise in the setting of chronic infection. For certain viral-induced cancers, such as human papilloma virus (HPV)–associated cervical cancer, the integrated virus encodes oncogenes that directly drive the transformation of infected cells. However, the vast majority of infection-associated cancers arise from chronic immune responses that, although ineffective in eliminating the inciting microbe, collaborate with microbial products to drive carcinogenesis. As many as one-third of cancers worldwide, particularly epithelial cancers, are associated with identified single microbial infections, leading to the conceptual paradigm that chronic infection with specific microbes causes these cancers, independent of other components of the ambient microbial community. In addition to cervical cancer and HPV, other well-established examples include gastric cancer and Helicobacter pylori, liver cancer and hepatitis B and C viruses, urinary bladder cancer and Schistosoma hematobium, and biliary tree cancer, Clonorchis sinensis, and Opisthorchis viverrini. A contrasting view of microbial carcinogenesis has been applied to colon cancer, the second leading cause of death due to cancer among adults in the United States. On the basis of increasingly high through put methods, we now understand that the colon is home to one of the most dense and diverse communities of bacteria in the body and that, although clustering of the colon microbiome sequences may occur in families or under similar close-contact conditions, we are all remarkably unique in our bacterial make up [1–2]. Indeed, beginning in the 1960s, investigators postulated and pursued links between the complex colon commensal flora and colon cancer [3]. Our recent work demonstrating the capacity of a specific human colonic bacterium, enterotoxigenic Bacteroides fragilis (ETBF), to induce colon tumors in multiple intestinal neoplasia (Min) mice [4] leads us to propose the “Alpha-bug hypothesis,” which integrates the single microbe and microbiome community views of microbial carcinogenesis. While we focus on colon carcinogenesis as an example, we propose that the Alpha-bug hypothesis might apply to other cancer types as well as other chronic immune-based pathology such as inflammatory bowel disease (IBD). Understanding how our colon bacterial communities contribute to the pathogenesis of colon cancer will require understanding the tripartite relationship depicted in Figure 1. This tripartite relationship positions members of the colon microbiome at its apex to suggest that bacteria are the key drivers of the mucosal immune response and subsequent changes in epithelial cell function and genetics that underpin oncogenic transformation. Colonic epithelial cells (CEC) possessing genetic or epigenetic mutations that disorder cell signaling and function are the cells of origin for colon cancer. It is estimated that clinical colon cancer emerges after a 20- to 40-year span in which sufficient CEC mutations accumulate to permit oncogenic transformation. Mucosal inflammation is integral to understanding colon cancer pathogenesis based on the strong clinical link of intestinal neoplasia and IBD such as Crohn’s disease and ulcerative colitis together with the recent demonstration of key molecular links between innate and adaptive immune responses and epithelial cancers. Further microbiome studies in IBD patients serve to well illustrate that microbiome dysbiosis is usual with chronic intestinal inflammation [5]. Tripartite relationship contributing to colon cancer pathogenesis. The microbiome, colonic mucosal immune balance, and colonic epithelial cell (CEC) responses (to the microbiome and mucosal immune responses) and CEC genetics are proposed to collectively contribute to the pathogenesis of colon cancer. Colon cancer has not yet been epidemiologically linked to a single microbe, raising the alternative idea that it is driven by multiple members of the complex colonic microbial community [6–8 ]. So how might the microbiota play a role in colon oncogenesis? One hypothesis might be that the colonic bacterial species act collectively to induce colon cancer in specific hosts (with possibly host gene polymorphisms leading to subtle pro-tumor mucosal immune responses), particularly if the host is ingesting a cancer-prone diet. This builds on the often-cited epidemiologic data indicating that the colon cancer risk of a migrating population will assume that of their resident country [7]. The more conventional hypothesis is that select microbiome members are sufficiently dominant that they alone define the oncogenic risk. This is, in essence, our clinical construct for diarrheal disease pathogenesis. If an individual develops diarrhea and a Shigella spp. is isolated from his or her feces, the person is designated as a case of shigellosis. While numerous organisms ha
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The keystone-pathogen hypothesis88 and the α-bug hypothesis both state that certain, low abundance microbiota members (such as enterotoxigenic B. fragilis) possess unique virulence traits, which are pro-oncogenic and remodel the microbiome and in turn promote mucosal immune responses and colonic epithelial cell changes.89”
From The gut microbiota and host health: a new clinical frontier (2016) · cites this paper as [89]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Frank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611
Bacterial Community Variation in Human Body Habitats Across Space and Time
Costello, E. K., Lauber, C. L., Hamady, M., Fierer, N., Gordon, J. I., & Knight, R. (2009) · Science · doi:10.1126/science.1177486 · Cited by 3,231
NF-κB: linking inflammation and immunity to cancer development and progression
Karin, M., & Greten, F. R. (2005) · Nature reviews. Immunology · doi:10.1038/nri1703 · Cited by 3,175
Molecular Basis of Colorectal Cancer
Markowitz, S. D., & Bertagnolli, M. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804588 · Cited by 2,052
Terzić, J., Grivennikov, S., Karin, E., & Karin, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.058 · Cited by 1,974
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
Yu, H., Kortylewski, M., & Pardoll, D. M. (2006) · Nature reviews. Immunology · doi:10.1038/nri1995 · Cited by 1,841
Self-citationWu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812
Self-citationMartin, H., Campbell, B. J., Hart, C. A., Mpofu, C., Nayar, M. K., Singh, R., Englyst, H. N., Williams, H. F., & Rhodes, J. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.054 · Cited by 719
Cited by
Sorted by citations
Items 201–259 of 259
Microbiota as a modulator of drug response: targeting microbial–drug crosstalk in cancer therapy
Zhao, T., Liu, M., Qiu, L. X., Zhang, H., Zhang, N., Liu, Z., Xia, Z., Luo, P., Huang, J., & Cheng, Q. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2651930 · Cited by 1
Microbiomics: Novel Biomarkers of Colorectal Cancer Diagnosis and Prognosis
Yang, L., Meng, W., Yang, T., Zhu, Y., & Wang, Z. (2026) · Diagnostics · doi:10.3390/diagnostics16111582 · Cited by 1
Chouaibi, S., Fertitta, V., Porreca, S., Njim, L., Carcagnì, A., Toietta, G., Canettieri, G., Zouari, K., Mastouri, M., Kadri, Y., et al. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2681818 · Cited by 1
The gut microbiome and colorectal cancer
Dietz, M. A., Subramanian, S., & Staley, C. M. (2026) · Clinical Microbiology Reviews · doi:10.1128/cmr.00332-25 · Cited by 1
Wrigley, S. D., Johnson, S. A., Gentile, C. L., & Weir, T. L. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1790805 · Cited by 1
Rôle des génotoxines produites par des bactéries du microbiote dans le cancer colorectal
Petit, C. R., Oswald, É., & Nougayrède, J. (2013) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(13)72226-3 · Cited by 1
What can gut bacteria tell us about colorectal cancer?
Tjalsma, H. (2012) · Colorectal Cancer · doi:10.2217/crc.12.44 · Cited by 1
Theodoropoulos, G. E. (2021) · The microbiomes of humans, animals, plants, and the environment · doi:10.1007/978-3-030-59642-2_4 · Cited by 1
Ecosystemic Approach to Understanding Gut Microbiome–Mediated Prevention of Colorectal Cancer
Lutsiv, T., Hussan, H., & Thompson, H. J. (2024) · The Cancer Journal · doi:10.1097/ppo.0000000000000743 · Cited by 2
Colorectal cancer and the microbiome: dysplasia, probiotics, and Fusobacterium nucleatum
Walker, W. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819672-4.00005-2 · Cited by 1
Dysbiosis in Microbiome Leading to Colitis-Associated Cancer
Priyamvada, P. (2021) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-3580-6.ch007 · Cited by 1
Role of microbiome in cancer immunotherapy
Russo, E., Boem, F., & Amedei, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823397-9.00010-7 · Cited by 1
Bacteremia and colon cancer: Causality or coincidence?
Corredoira, J., & Ayuso, B. (2022) · Enfermedades infecciosas y microbiologia clinica (English ed ) · doi:10.1016/j.eimce.2022.02.012 · Cited by 1
Weir, T. L. (2014) · Translational gastrointestinal cancer
Microbiome Implications in Intestinal Tumorigenesis
Posocco, D. F., Dmitrieva, O., & Grivennikov, S. I. (2015) · Springer eBooks · doi:10.1007/978-3-319-19986-3_7
Colon Cancer and IBD: Potential Links to Race, Microbiota
Robinson, C. J., Ashktorab, H., Brim, H., Lee, E. L., & Eribo, B. E. (2013) · Microbe Magazine · doi:10.1128/microbe.8.243.1
Permissive/Protective Interplay of Microbiota with T Cell Adaptive Immune Response in Colon Cancer
Mojtahedi, Z., Rezaeifard, S., & Faghih, Z. (2016) · Annals of Colorectal Research · doi:10.17795/acr-43883
dos Santos, C. S. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.9.2016.tde-12072016-144758
McFarlane, M. J. (2026) · Warwick Research Archive Portal (University of Warwick) · doi:10.82444/warw.33769063
Influence of bilberry-derived anthocyanidins on key regulators of colorectal cancer development.
Mudd, A. M. (2018) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/3129
Microbiota: Novel Gateway Towards Personalised Medicine
Žučko, J., Starčević, A., Diminić, J., & Oros, D. (2019) · Europeanization and globalization · doi:10.1007/978-3-030-16465-2_9
Nutrition, the Gastrointestinal Microbiota and Cancer Prevention
Lopes, R. G., do Prado, S. B. R., & Fabi, J. P. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781788016506-00261
The Role of Gut Microbiota Dysbiosis in Gastrointestinal Carcinogenesis
Bartolini, I., & Amedei, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00063-2
Current Knowledge About the Implication of Bacterial Microbiota in Human Health and Disease
Nikolova, D. N. (2021) · Acta Medica Bulgarica · doi:10.2478/amb-2021-0047
Microbiota y su relación en el cáncer
Ordóñez, G. D. B., Anguisaca, C. F. O., & Carpio, C. A. M. (2021) · Revista del Centro de Investigación de la Universidad la Salle · doi:10.26457/recein.v14i56.2853
Bacteremia and colon cancer: Causality or coincidence?
Corredoira, J., & Ayuso, B. (2022) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2022.02.003
Colorectal Cancer-Associated Microbiota
Tjalsma, H., Dutilh, B. E., Boleij, A., & Marchesi, J. R. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6418-1_774-1
Colorectal Cancer-Associated Microbiota
Tjalsma, H., Dutilh, B. E., Boleij, A., & Marchesi, J. R. (2015) · Springer eBooks · doi:10.1007/978-1-4899-7475-4_774
Research Progress on the Difference between Left and Right Colon Cancer
翟, 丁. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.127866
Alberca, G. G. F. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2020.tde-13012022-153608
Data from The Microbiome and Cancer: Creating Friendly Neighborhoods and Removing the Foes Within
Parida, S., & Sharma, D. (2023) · doi:10.1158/0008-5472.c.6512508.v1
Probiotics Based Anticancer Immunity in Colorectal Cancer
Giri, P. S., & Dwivedi, M. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815124781123030008
The Interplay Between Immunity and Gut Microbiota in Colon Cancer
Malaspina, L., Petrelli, F., Perotti, B., Arganini, M., & Ambrosio, M. R. (2023) · Interdisciplinary cancer research · doi:10.1007/16833_2023_179
A comparative study of gut microbiota in the healthy elderly and the elderly with colorectal cancer
Iadsee, N. (2021) · Chula Digiverse · doi:10.58837/chula.the.2021.246
Gut microbiome as a tumor promoter and tumor suppressor
Yadav, T., Syal, R., & Tripathi, C. (2023) · Microsphere · doi:10.59118/yqei2382
Gut dysbiosis and colorectal cancer: from oncogenesis hypotheses to non-invasive diagnostics
Glazunova, E. V., Kurnosov, A., & Zlobovskaya, O. A. (2024) · Bulletin of Russian State Medical University · doi:10.24075/brsmu.2024.046
The Impact of the Appendix on Intestinal Microbiome and Colorectal Cancer
王, 钟. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1551508
Altork, N. A., Chameli, T., Suvarnakar, A. M., Ayers, L. R., Arman, A., Al-Hamadani, M., Peppas, S., Ahmad, A. I., Chou, J., & Mattar, M. C. (2025) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000003007 · Cited by 1
Clostridioides difficile: A suspected pro-carcinogenic bacterium for gastrointestinal tumors
Zou, J., Tian, B., Xiao, Y., Wu, A., & Li, C. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003834
Janati, A. I., Karp, I., Laprise, C., Sabri, H., & Emami, E. (2020) · Figshare · doi:10.6084/m9.figshare.13331949
Wang, S., Kou, G.-J., Zhao, X.-H., Huang, G., Wang, J., Tian, L., Zuo, X.-L., Li, Y.-Q., Wang, J., & Yu, Y.-B. (2024) · Figshare · doi:10.6084/m9.figshare.26713619
Wang, S., Kou, G.-J., Zhao, X.-H., Huang, G., Wang, J., Tian, L., Zuo, X.-L., Li, Y.-Q., Wang, J., & Yu, Y.-B. (2024) · Figshare · doi:10.6084/m9.figshare.26713613
Loftus, M., Hassouneh, S. A.-D., & Yooseph, S. (2021) · Figshare · doi:10.6084/m9.figshare.14355517
Wang, S., Kou, G.-J., Zhao, X.-H., Huang, G., Wang, J., Tian, L., Zuo, X.-L., Li, Y.-Q., Wang, J., & Yu, Y.-B. (2024) · Figshare · doi:10.6084/m9.figshare.26713616
Wang, S., Kou, G.-J., Zhao, X.-H., Huang, G., Wang, J., Tian, L., Zuo, X.-L., Yanqing, L. I., Wang, J., & Yu, Y.-B. (2024) · Figshare · doi:10.6084/m9.figshare.26713622
Vitamin C in the Treatment of Colorectal Cancer: Between Hope and Despair
Wasmer, M., Weber, M., & Faes, S. (2026) · Cancers · doi:10.3390/cancers18040654
The role of gut microbiota and its metabolites in preventing oncogenesis
Li, Z., Yan, J., Zeng, Z., & Zhao, L. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1790063
Microbiome influence on cancer
Khan, F., Ahmed, S., & Tayyaba, U. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40551-8.00005-6
Kuntal, B. K., Bose, T., & Dutta, A. (2026) · Methods in molecular biology · doi:10.1007/978-1-0716-5080-6_7
Zhu, Y., Luo, S., Luo, Y., Guo, Z., Jiang, Y., Ma, Q., Fu, X., Zheng, C., You, F., Kuang, Q., et al. (2026) · Virulence · doi:10.1080/21505594.2026.2673632
Cristinescu, B. A., Dura, H., Fleacă, R. S., Onișor, D. M., Brusnic, O., Porr, C., Bîrsan, S., & Boicean, A. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15145331
Virulome over taxonomy: refining the driver-passenger model in colorectal carcinogenesis
Glazunova, E. V., Kurnosov, A., Bogacheva, A., Makarov, V., & Zlobovskaya, O. A. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1858868
Genetic profiling of biofilm-associated cancers: Towards personalized medicine
Roy, S., Ghosh, S., Hansda, S., Karmakar, S., Ghosh, G., & Ghosh, S. (2026) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2026.07.002
Escudero-Jiménez, Á., Ros, J. G., Huertas-López, F., Pérez-Sarabia, A., Ribeiro, D., Postigo-Corrales, F., Albaladejo-González, A., Díaz-López, M. I., López-Abellán, M. D., García-Rodríguez, J., et al. (2026) · mSystems · doi:10.1128/msystems.00622-26
Wang, C., Shi, L., Jin, G., Yonghong.Yang, Zhu, F., & Zhou, G. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105562
Messiha, K., Khan, S., Houshyar, Y., Damm, G. K., & Hold, G. L. (2026) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2026.102139
Microbiome-based diagnostics and biomarkers: The search for mechanistic connections
Kumari, N., Allani, S. K., Knapinska, A., & Bommareddy, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33206-7.00004-2
Coelho, C. P. E. S., Munduri, J. M. D. S., Oliveira, J. A. D. V. C., Moreira, M. I., de Cena, J. A., & Damé‐Teixeira, N. (2026) · Journal of Applied Oral Science · doi:10.1590/1678-7765-2026-0384
Cheng, S., Zhang, Y., Li, W., Xu, G., & Qu, J. (2026) · Biomedicines · doi:10.3390/biomedicines14112485
Metadata
- Authors
- Sears, C. L., & Pardoll, D. M.
- Affiliations
- Johns Hopkins University (US)
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-02-01
- Volume
- 203
- Issue
- 3
- Pages
- 306-311
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- PMC
- PMC3071114
- OpenAlex
- W2096233985
- Cited by
- 259
- References
- 29
- Citations by year
- 2026: 22 · 2025: 13 · 2024: 25 · 2023: 23 · 2022: 18 · 2021: 23 · 2020: 21 · 2019: 19 · 2018: 17 · 2017: 13 · 2016: 15 · 2015: 7 · 2014: 12 · 2013: 16 · 2012: 11
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Johns Hopkins University
- National Cancer Institute (R01CA151325, R01CA151393)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK045496, R01DK080817, R01DK059655)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- colon cancer, colon microbiome, enterotoxigenic Bacteroides fragilis, microbial carcinogenesis, chronic infection, mucosal immune response, oncogenic transformation, ApcMin/+ mice, inflammatory bowel disease
- MeSH terms
- Bacteria, Colon, Colonic Neoplasms, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
